Matches in DBpedia 2014 for { ?s ?p ABT-418 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors. It binds with high affinity to the α4β2, α2β2 and α7 subtypes, but not to the α3β4 subtype. It has nootropic, neuroprotective and anxiolytic effects, and has been researched for treatment of both Alzheimer's disease and more recently ADHD.. }
Showing items 1 to 1 of
1
with 100 items per page.
- ABT-418 comment "ABT-418 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors. It binds with high affinity to the α4β2, α2β2 and α7 subtypes, but not to the α3β4 subtype. It has nootropic, neuroprotective and anxiolytic effects, and has been researched for treatment of both Alzheimer's disease and more recently ADHD.".